黑料网

ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Clin Exp Pathol 2018, Vol 8(3): 348
  • DOI: 10.4172/2161-0681.1000348

Epidermal Growth Factor Immunotherapy: Exploring the Effects of NB-UVB Exposure.

E. Costantini1*, R. Muraro1, C. D’Angelo1, M. De Tursi1, C. Natoli1, M. Auriemma2, M. Di Nicola1, M. Reale2 and P. Amerio1
1Department of Medical, Oral and Biotechnological Sciences, D'Annunzio University of Chieti–Pescara, Italy
2Department of Medicine and Aging Sciences, D'Annunzio University of Chieti–Pescara, Italy
*Corresponding Author : E. Costantini, Department of Medical, Oral and Biotechnological Sciences, D'Annunzio University of Chieti–Pescara, Italy, Tel: +3908713554026, Email: erica.costantini@unich.it

Received Date: Jun 25, 2018 / Accepted Date: Jul 12, 2018 / Published Date: Jul 17, 2018

Keywords: NB-UVB; HaCaT; Cytokines; Cetuximab

Citation: Costantini E, Angelo C, Muraro R, Tursi M, Natoli C, et al. (2018) Epidermal Growth Factor Immunotherapy: Exploring the Effects of NB-UVB Exposure. J Clin Exp Pathol 8:348. Doi: 10.4172/2161-0681.1000348

Copyright: © 2018 Costantini E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top